US Stem Cell FDA

Clinic biz US Stem Cell reports SEC subpoena, adding to uncertainty on its future

US-Stem-Cell-Clinic

The last few years for the publicly-traded stem cell clinic biz, US Stem Cell, Inc., which goes by the ticker $USRM, have seemed like a rollercoaster to me as an observer. I can see four main areas of news that to me make the future seem uncertain for this firm. First, the US Stem was linked to the …

Clinic biz US Stem Cell reports SEC subpoena, adding to uncertainty on its future Read More »